The Prognostic Value of Preoperative Neutrophil-to-Lymphocyte Ratio in Colorectal Cancer

World Journal of Surgery

Volumn 40, Issue 11, 2016, Pages 2796-2802

  Kubo, Hidemasa ^a   Murayama, Yasutoshi ^a   Arita, Tomohiro ^a   Kuriu, Yoshiaki ^a   Nakanishi, Masayoshi ^a   Otsuji, Eigo ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CARCINOEMBRYONIC ANTIGEN; SERUM ALBUMIN;

AGED; BLOOD; COLORECTAL NEOPLASMS; FEMALE; HUMAN; LYMPHOCYTE; MALE; METABOLISM; MORTALITY; NEUTROPHIL; PREOPERATIVE PERIOD; PROGNOSIS; RETROSPECTIVE STUDY;

AGED; C-REACTIVE PROTEIN; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LYMPHOCYTES; MALE; NEUTROPHILS; PREOPERATIVE PERIOD; PROGNOSIS; RETROSPECTIVE STUDIES; SERUM ALBUMIN;

EID: 84974853731     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-016-3595-x     Document Type: Article

References (34)

1. Jemal A, Bray F, Center MM et al (2011) Global cancer statistics. CA Cancer J Clin 61:69–90
2. Center for Cancer Control and Information Services, National Cancer Center, Japan. Statistics. http://ganjoho.jp/reg_stat/statistics/index.html
3. Sobin LH, Gospodarowicz MK, Wittekind C (2009) TNM classification of malignant tumors, 7th edn. Wiley, Chichester
4. Japanese Society for Cancer of the Colon and Rectum (2013) Japanese classification of colorectal carcinoma, 8th edn. Kanehara & CO., Ltd, Tokyo
5. Choi KW, Hong SW, Chang YG et al (2014) Inflammation-based score (Glasgow prognostic score) as an independent prognostic factor in colorectal cancer patients. Ann Surg Treat Res 86(6):309–313
6. Gibbs J, Cull W, Henderson W et al (1999) Preoperative serum albumin level as a predictor of operative mortality and morbidity: results from the National VA Surgical Risk Study. Arch Surg 134:36–42
7. Walker KG, Bell SW, Rickard MJ et al (2004) Anastomotic leakage is predictive of diminished survival after potentially curative resection for colorectal cancer. Ann Surg 240(2):255–259
8. McArdle CS, McMillan DC, Hole DJ (2005) Impact of anastomotic leakage on long-term survival of patients undergoing curative resection for colorectal cancer. Brit J Surg 92(9):1150–1154
9. Chua W, Clarke SJ, Charles KA (2012) Systemic inflammation and prediction of chemotherapy outcomes in patients receiving docetaxel for advanced cancer. Support Care Cancer 20(8):1869–1874
10. Wang DS, Luo HY, Qiu MZ et al (2012) Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer. Med Oncol 29(5):3092–3100
11. Sarraf KM, Belcher E, Raevsky E et al (2009) Neutrophil/lymphocyte ratio and its association with survival after complete resection in non–small cell lung cancer. J Thorac Cardiovasc Surg 137(2):425–428
12. Yuan D, Zhu K, Li K et al (2014) The preoperative neutrophil–lymphocyte ratio predicts recurrence and survival among patients undergoing R0 resections of adenocarcinomas of the esophagogastric junction. J Surg Oncol 110(3):333–340
13. Yu L, Lv CY, Yuan AH, Chen W et al (2015) Significance of the preoperative neutrophil-to-lymphocyte ratio in the prognosis of patients with gastric cancer. World J Gastroentero 21(20):6280–6286
14. Kos FT, Hocazade C, Kos M et al (2014) Assessment of prognostic value of “neutrophil to lymphocyte ratio” and “prognostic nutritional index” as a systemic inflammatory marker in non-small cell lung cancer. Asian Pac J Cancer Prev 16(9):3997–4002
15. Rachidi S, Wallace K, Wrangle JM, et al (2015) Neutrophil‐to‐lymphocyte ratio and overall survival in all sites of head and neck squamous cell carcinoma. Head Neck
16. Kishi Y, Kopetz S, Chun YS et al (2009) Blood neutrophil-to-lymphocyte ratio predicts survival in patients with colorectal liver metastases treated with systemic chemotherapy. Ann Surg Oncol 16(3):614–622
17. Chua W, Charles KA, Baracos VE et al (2011) Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer. Br J Cancer 104(8):1288–1295
18. He W, Yin C, Guo G et al (2013) Initial neutrophil lymphocyte ratio is superior to platelet lymphocyte ratio as an adverse prognostic and predictive factor in metastatic colorectal cancer. Med Oncol 30(1):1–6
19. Formica V, Luccchetti J, Cunningham D et al (2014) Systemic inflammation, as measured by the neutrophil/lymphocyte ratio, may have differential prognostic impact before and during treatment with fluorouracil, irinotecan and bevacizumab in metastatic colorectal cancer patients. Med Oncol 31(9):1–8
20. Chen ZY, Raghav K, Lieu CH et al (2015) Cytokine profile and prognostic significance of high neutrophil-lymphocyte ratio in colorectal cancer. Br J Cancer 112(6):1088–1097
21. Chiang SF, Hung HY, Tang R et al (2012) Can neutrophil-to-lymphocyte ratio predict the survival of colorectal cancer patients who have received curative surgery electively? Int J Colorectal Dis 27(10):1347–1357
22. Ding PR, An X, Zhang RX et al (2010) Elevated preoperative neutrophil to lymphocyte ratio predicts risk of recurrence following curative resection for stage IIA colon cancer. Int J Colorectal Dis 25(12):1427–1433
23. Hung HY, Chen JS, Yeh CY et al (2011) Effect of preoperative neutrophil–lymphocyte ratio on the surgical outcomes of stage II colon cancer patients who do not receive adjuvant chemotherapy. Int J Colorectal Dis 26(8):1059–1065
24. Walsh SR, Cook EJ, Goulder F et al (2005) Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol 91(3):181–184
25. Li MX, Liu XM, Zhang XF et al (2014) Prognostic role of neutrophil-to-lymphocyte ratio in colorectal cancer: a systematic review and meta-analysis. Int J Cancer 134(10):2403–2413
26. Park JJ, Jang HJ, Oh IY et al (2013) Prognostic value of neutrophil to lymphocyte ratio in patients presenting with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Am J Cardiol 111(5):636–642
27. Akobeng AK (2007) Understanding diagnostic tests 3: receiver operating characteristic curves. Acta Paediatr 96:644–647
28. Watanabe T, Itabashi M, Shimada Y et al (2015) Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer. Int J Clin Oncol 20(2):207–239
29. Mantovani A, Allavena P, Sica A et al (2008) Cancer-related inflammation. Nature 454(7203):436–444
30. Triantafillidis JK, Nasioulas G, Kosmidis PA (2009) Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies. Anticancer Res 29(7):2727–2737
31. Ropponen K, Tammi M, Parkkinen J et al (1998) Tumor cell-associated hyaluronan as an unfavorable prognostic factor in colorectal cancer. Cancer Res 58(2):342–347
32. Ohtani H (2007) Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human colorectal cancer. Cancer Immun 7(1):4
33. Omran ML, Morley JE (2000) Assessment of protein energy malnutrition in older persons, part II: laboratory evaluation. Nutrition 16(2):131–140
34. Mohri Y, Inoue Y, Tanaka K et al (2013) Prognostic nutritional index predicts postoperative outcome in colorectal cancer. World J of Surg 37(11):2688–2692. doi:10.1007/s00268-013-2156-9